A proteomics study of extracellular vesicles separated from cerebrospinal fluid (CSF) of AD showed that the expression level of HSPA1A was higher in the AD group than in the MCI and CTRL groups, and it might be used to monitor the progression of MCI to AD [44]. This evidence concerns the gene HSPA1A and Alzheimer disease.